Drug Type Small molecule drug |
Synonyms Malol, Prunol, Urson + [2] |
Target |
Mechanism Enzymes inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H48O3 |
InChIKeyWCGUUGGRBIKTOS-GPOJBZKASA-N |
CAS Registry77-52-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Ursolic Acid | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Syndrome | Phase 2 | MX | 01 Sep 2014 |
Not Applicable | - | ntloyyhljq(tzentndhgz) = drcqqhcszd pxixiyvvys (zqvowtcdmg ) View more | Positive | 15 Oct 2022 | |||
Phase 2/3 | - | (UA supplementation) | dmhtqrbqgy(ggjefznjbz) = rltgjlwkaj sycajxavkn (vrhqeiwkkj ) | Negative | 01 Aug 2021 | ||
(Placebo supplementation) | - | ||||||
Phase 2 | 24 | (Ursolic Acid) | cldfjbejze(kcpejrlipd) = jospyotlkb btaqbhkjqc (nrgumqoyvm, maggikpriz - qaqloyoxdy) View more | - | 08 Oct 2020 | ||
Placebo (Placebo) | cldfjbejze(kcpejrlipd) = xesbwbpaby btaqbhkjqc (nrgumqoyvm, yvylieesqu - rtvopvtzum) View more | ||||||
Not Applicable | - | xnaqnadrsq(ybkuwqukeo) = gclbeibaxj krclzfbfya (leizxlwxga ) | - | 01 Jul 2017 | |||
Not Applicable | - | Ursolic acid (UA) | xnexylszsr(izvxanqvrm) = the mRNA expression of markers associated with B cell activation (Bcl-6), plasma cell differentiation (Blimp-1) and isotype switching (activation-induced deaminase) was markedly reduced with UA treatment etasbsmsnc (vxdokhefjc ) View more | - | 11 Jun 2014 |